hero-transparent

SOLUTION

img

Biotech & Life Sciences Investments

At Jameel Health, we provide integrated distribution and in-market services solutions for our partners, opening new opportunities across the developing world to accelerate access to modern health care for those that need it most – but we’re doing so much more through our targeted investments.

Jameel Health reflects the Jameel Family’s long-established commitment to innovating for a better future through Community Jameel, an international organization supporting science and technology-led solutions to global challenges.  Community Jameel and MIT co-founded the Abdul Latif Jameel Clinic for Machine Learning in Health (Jameel Clinic) in September 2018 – which has rapidly become the very epicenter of AI and healthcare at MIT – and the Abdul Latif Jameel Institute for Disease and Emergency Analytics (Jameel Institute) co-founded with Imperial College London, in October 2019, using novel data analytics to reduce global risk of preventable disease most recently including the 2020 COVID-19 pandemic, and strengthening health systems in the most fragile settings.

Jameel Health takes this commitment into the commercial environment addressing tangible real-world needs today, for a healthier tomorrow, focused on health care inclusion in the global south, accelerating access to modern medical care for those who need it most by opening up/growing new markets for distribution of existing solutions and investing in the future.

Through its dedicated biotech fund, the JIMCO Life Sciences Fund, JIMCO, the investment arm of the Jameel Family, actively invests in innovative, early-stage and breakthrough ventures and technology, aiming to positively shape the future of core industries driving the global health economy, from pharmaceuticals and vaccines to cutting-edge medical devices, technology and techniques.

Other partners

 down prev-arrow
 down next-arrow